What’s new

Find all new and updated information published on our website in one place below. Filters are available to narrow results down based on your interests, such as whether it relates to human or veterinary medicines or specific topics. Information on medicines and related procedures includes a reference to relevant substances: INN or common name, active substance, and English common name for herbal products. This overview covers up to two months back.

We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours.

As of 1 October 2025, information on medicines and related procedures includes a reference to relevant substances: INN or common name, active substance, and English common name for herbal products.

Results (84)

Date	Content	Status
04/03/2026	Medicine: Eylea aflibercept	Updated
04/03/2026	Page: Plasma master file certificates	Updated
04/03/2026	Medicine: mNexspike COVID-19 mRNA vaccine	Updated
04/03/2026	Medicine: Kefdensis denosumab	Updated
04/03/2026	Medicine: Otezla apremilast	Updated
04/03/2026	Medicine: Vitrakvi larotrectinib	Updated
04/03/2026	Medicine: Leqvio inclisiran	Updated
04/03/2026	Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)	Updated
04/03/2026	PIP: EMA/PE/0000230484 - paediatric investigation plan alprazolam	Updated
04/03/2026	PIP: EMA/PE/0000227908 - paediatric investigation plan nerandomilast	Updated
04/03/2026	PIP: EMA/PE/0000227558 - paediatric investigation plan danicopan	Updated
04/03/2026	PIP: EMA/PE/0000227526 - paediatric investigation plan ceftobiprole medocaril (sodium)	Updated
04/03/2026	PIP: EMA/PE/0000227462 - paediatric investigation plan deucrictibant monohydrate	Updated
04/03/2026	PIP: EMA/PE/0000227425 - paediatric investigation plan efgartigimod alfa	Updated
04/03/2026	Medicine: Hemgenix etranacogene dezaparvovec	Updated
04/03/2026	PIP: EMA/PE/0000227394 - paediatric investigation plan tezacaftor; ivacaftor	Updated
04/03/2026	PIP: EMA/PE/0000226957 - paediatric investigation plan efgartigimod alfa	Updated
04/03/2026	Document: Draft guidance on the conduct of clinical trials during public health emergencies	New
04/03/2026	Document: Records of data processing activity for the handling the contribution towards commuting costs	Updated
04/03/2026	Medicine: Xevudy sotrovimab	Updated
04/03/2026	Page: Data Analysis and Real World Interrogation Network (DARWIN EU)	Updated
04/03/2026	Document: DARWIN EU Advisory Board: Membership	Updated
04/03/2026	Document: DARWIN EU data partners onboarded in phases I, II and III	Updated
04/03/2026	Document: Darwin EU: Making health data count	Updated
04/03/2026	Document: Darwin EU study: Co-prescribing medicines in pulmonary arterial hypertension	New
04/03/2026	Document: Darwin EU study: How medicines are used to treat adults and children with lupus	New
04/03/2026	Document: Darwin EU study: Clozapine and the incidence of severe neutropenia over time	New
04/03/2026	Document: Darwin EU study: Treatment patterns and user characteristics for novel migraine medicines	New
04/03/2026	Document: Darwin EU study: Overall survival in patients with non-small cell lung cancer treated with selected immunotherapies	New
04/03/2026	Document: Darwin EU: Is there a risk of suicidality after taking the antibiotic doxycycline	New
04/03/2026	Document: Darwin EU study: Is there a link between blood clots and common painkillers in women who use hormonal birth control	New
04/03/2026	Document: Darwin EU: How often respiratory syncytial virus (RSV) affects different age groups in Europe	New
04/03/2026	Document: Darwin EU study: Use of higher-risk antibiotics from the WHO Watch list, including azithromycin	New
04/03/2026	Document: Darwin EU study: Background incidence rates of selected vaccine adverse events of special in Europe	New
04/03/2026	Document: Minutes of the CAT meeting 21-23 January 2026	New
03/03/2026	Document: Annual report on the use of the special contribution for orphan medicinal products - 2025	New
03/03/2026	Document: Questions and answers on the use of out-of-specification batches of authorised cell and tissue-based advanced therapy medicinal products	Updated
03/03/2026	Document: Consolidated 3-year work plan for the clinical domain	New
03/03/2026	Document: Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 February 2026	New
03/03/2026	Page: Medicines for human use under evaluation	Updated
03/03/2026	PIP: EMA/PE/0000228283 - paediatric investigation plan balstilimab	New
03/03/2026	Medicine: Afqlir aflibercept	Updated
03/03/2026	Shortage: Ifosfamide ifosfamide	Updated
03/03/2026	Shortage: Cyclophosphamide cyclophosphamide	Updated
03/03/2026	Event: Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party	Updated
03/03/2026	PIP: EMA/PE/0000226753 - paediatric investigation plan mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein; mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein; mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein	New
03/03/2026	Medicine: Entyvio vedolizumab	Updated
03/03/2026	News: Human medicines: highlights of 2022	Updated
03/03/2026	Document: Human medicines highlights 2022	Updated
03/03/2026	Medicine: Zeposia ozanimod	Updated
03/03/2026	Medicine: Vyloy zolbetuximab	Updated
03/03/2026	Medicine: Myqorzo aficamten	Updated
03/03/2026	Medicine: Aqneursa L-acetylleucine	Updated
03/03/2026	Page: Artificial intelligence	Updated
03/03/2026	Document: Scientific Explorer - Frequently Asked Questions	Updated
03/03/2026	Document: Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6	Updated
02/03/2026	Page: Fees for veterinary medicines	Updated
02/03/2026	Herbal: Combination: Hyperici herba - herbal medicinal product St. John's Wort	Updated
02/03/2026	Medicine: Lotilaner / Milbemycin Elanco lotilaner; milbemycin oxime	Updated
02/03/2026	Medicine: Nivestim filgrastim	Updated
02/03/2026	Medicine: Retacrit epoetin zeta	Updated
02/03/2026	Medicine: Lamzede velmanase alfa	Updated
02/03/2026	Medicine: Fingolimod Accord fingolimod	Updated
02/03/2026	Medicine: Rasilez aliskiren	Updated
02/03/2026	Event: 3Rs Working Party (3RsWP) stakeholder meeting - Public session on the 2026-2028 work plan	New
02/03/2026	Medicine: Pylclari piflufolastat (18F)	Updated
02/03/2026	Medicine: Herceptin trastuzumab	Updated
02/03/2026	Page: One Health approach	Updated
02/03/2026	Event: Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - February 2026	Updated
02/03/2026	Event: European Medicines Agency (EMA) and European Alliance of Associations for Rheumatology (EULAR) bilateral meeting	New
02/03/2026	Page: Medical devices	Updated
02/03/2026	Document: Report - Highlights of the 15th Industry Standing Group (ISG) meeting	Updated
02/03/2026	Page: Non-clinical development and evaluation of microbiome-based medicinal products - Scientific guideline	New
02/03/2026	Document: Draft concept paper on the development of a reflection paper on the non-clinical development and evaluation of microbiome-based medicinal products	New
02/03/2026	Medicine: Neoclarityn desloratadine	Updated
02/03/2026	Medicine: Nemluvio nemolizumab	Updated
02/03/2026	Medicine: Azomyr desloratadine	Updated
02/03/2026	Medicine: Aerius desloratadine	Updated
02/03/2026	Event: Electronic application form (eAF) Q&A clinic	Updated
02/03/2026	Medicine: Nexium Control esomeprazole	Updated
02/03/2026	Medicine: Xbonzy denosumab	Updated
02/03/2026	Page: Quality of medicines: questions and answers - Part 1	Updated
02/03/2026	Event: Healthcare Professionals' Working Party (HCPWP) plenary meeting February 2026	Updated
02/03/2026	Event: Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting	Updated

What’s new

Filter by

Results (84)